BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20030577)

  • 1. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods.
    Ladero JM; Delkader J; Ortega L; Fernández C; Devesa MJ; López-Alonso G; Mayol J; Cuenca F; Suárez A; Taxonera C; Díaz-Rubio M
    Scand J Gastroenterol; 2010; 45(1):51-9. PubMed ID: 20030577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
    Wai CT; Greenson JK; Fontana RJ; Kalbfleisch JD; Marrero JA; Conjeevaram HS; Lok AS
    Hepatology; 2003 Aug; 38(2):518-26. PubMed ID: 12883497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
    Coco B; Oliveri F; Maina AM; Ciccorossi P; Sacco R; Colombatto P; Bonino F; Brunetto MR
    J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.
    Sturm N; Marlu A; Arvers P; Zarski JP; Leroy V
    Liver Int; 2013 Mar; 33(3):428-38. PubMed ID: 23402612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
    Sebastiani G; Vario A; Guido M; Noventa F; Plebani M; Pistis R; Ferrari A; Alberti A
    J Hepatol; 2006 Apr; 44(4):686-93. PubMed ID: 16490278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
    Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Mubarak A
    J Ayub Med Coll Abbottabad; 2008; 20(4):122-6. PubMed ID: 19999223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utility of 2 biochemical models predictive of liver fibrosis grade in prison inmates with hepatitis C].
    Portilla J; López-Burgos A; Saiz-De-La-Hoya-Zamácola P; Sánchez-Payá J; Bedía-Collantes M; Faraco-Atienzar I; Lissen E
    Gastroenterol Hepatol; 2009; 32(6):387-94. PubMed ID: 19477553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S; Memon MS; Ghani H; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is APRI score a suitable tool for prediction of fibrosis in Tunisian patients with genotype 1 chronic viral hepatitis C?].
    Karoui S; Ben Romdhane S; Serghini M; Ben Mustapha N; Boubaker J; Haouet S; Filali A
    Tunis Med; 2012 Apr; 90(4):282-5. PubMed ID: 22535341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FibroScore for the non-invasive assessment of liver fibrosis in chronic viral hepatitis.
    Ashraf S; Ahmed SA; Ahmed J; Ali N
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):84-90. PubMed ID: 22313643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H; Cooper C; Murphy T; Klein MB
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C.
    Alsatie M; Kwo PY; Gingerich JR; Qi R; Eckert G; Cummings OW; Imperiale TF
    J Clin Gastroenterol; 2007 Apr; 41(4):416-21. PubMed ID: 17413613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.